Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

OBJECTIVE: We assessed national- and state-level geographic variations among patients with a history of ≥1 major atherosclerotic cardiovascular disease (ASCVD) event in: (1) the proportion of patients with retrospectively identified 2018 American College of Cardiology/American Heart Association guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Seth J., Rane, Pallavi B., Nunna, Sasikiran, Habib, Mohdhar, Philip, Kiran, Sun, Kainan, Wang, Xin, Wade, Rolin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315617/
https://www.ncbi.nlm.nih.gov/pubmed/34327500
http://dx.doi.org/10.1016/j.ajpc.2021.100177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315617/
https://www.ncbi.nlm.nih.gov/pubmed/34327500
http://dx.doi.org/10.1016/j.ajpc.2021.100177

Ejemplares similares